Language Select
Varian Logo

Press Releases

June 12, 2019
Varian (NYSE: VAR) will showcase and discuss its latest innovations in radiotherapy at the DEGRO 25 (German Society for Radio Oncology) meeting in Münster, Germany, June 13-16. At the core of the... Read more
June 11, 2019
Varian (NYSE: VAR) announced it will be showcasing its Bravos™ afterloader system for High Dose Rate (HDR) brachytherapy treatments and other advanced brachytherapy solutions at the 2019... Read more
June 10, 2019
Varian (NYSE: VAR) today announced it has acquired Austin, Texas-based Endocare and Hangzhou, China-based, Alicon, to expand its portfolio of multidisciplinary integrated cancer care solutions.... Read more
June 10, 2019
Varian (NYSE: VAR) today announced Herlev University Hospital near Copenhagen, Denmark is Scandinavia's first facility to utilize the Halcyon™ system. The first patient treated on the system was... Read more
June 07, 2019
Providing access to proton therapy treatment for cancer patients in the tri-state area, the New York Proton Center (NYPC) held a ribbon cutting event yesterday to commemorate the opening of the... Read more
June 07, 2019
Varian (NYSE: VAR) today announced it will be hosting its second FlashForward™ Consortium meeting at 12:00pm Tuesday, June 11th at the 58th annual Particle Therapy Co-Operative Group meeting... Read more
June 06, 2019
Varian (NYSE: VAR) announced it will be showcasing its new ProBeam® 360° proton therapy system*, June 12th-15th in Manchester, United Kingdom at the 58th PTCOG Conference (Particle Therapy... Read more
May 29, 2019
Varian (NYSE: VAR) today announced it will be showcasing its Noona® patient management system and its 360 Oncology™ care management platform, May 31-June 4 in Chicago, Illinois at the 2019 ASCO... Read more
May 28, 2019
Varian (NYSE: VAR) today announced a physicist using Varian's Eclipse™ treatment planning system achieved the top overall score in the TROG 2019 Stereotactic Body Radiation Therapy (SBRT)... Read more
May 20, 2019
Taking an important step to accelerate innovation of new multidisciplinary solutions to address the growing global cancer burden, Varian Medical Systems (NYSE: VAR) today announced it has entered... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com